Tucatin
Tucatin is Tucatinib, an oral HER2-selective tyrosine kinase inhibitor. It is indicated for HER2-positive advanced or metastatic breast cancer, including patients with brain metastases and works by selectively inhibiting HER2-driven signaling.
Features
| Product Name | Tucatin |
| Generic Name | Tucatinib |
| Formulation | Tablet |
| Available Pack Size | 7X4's |
| Available Strength | 150 mg |